FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384524084> ?p ?o ?g. }

• W4384524084 abstract "Abstract Treatment of patients with recent-onset type 1 diabetes with an anti-CD3 antibody leads to the transient stabilization of C-peptide levels in responder patients. Partial efficacy may be explained by the entry of islet-reactive T-cells spared by and/or regenerated after the anti-CD3 therapy. The CXCR3/CXCL10 axis has been proposed as a key player in the infiltration of autoreactive T cells into the pancreatic islets followed by the destruction of β cells. Combining the blockade of this axis using ACT-777991, a novel small-molecule CXCR3 antagonist, with anti-CD3 treatment may prevent further infiltration and β-cell damage and thus, preserve insulin production. The effect of anti-CD3 treatment on circulating T-cell subsets, including CXCR3 expression, in mice was evaluated by flow cytometry. Anti-CD3/ACT-777991 combination treatment was assessed in the virally induced RIP-LCMV-GP and NOD diabetes mouse models. Treatments started at disease onset. The effects on remission rate, blood glucose concentrations, insulitis, and plasma C-peptide were evaluated for the combination treatment and the respective monotherapies. Anti-CD3 treatment induced transient lymphopenia but spared circulating CXCR3+ T cells. Combination therapy in both mouse models synergistically and persistently reduced blood glucose concentrations, resulting in increased disease remission rates compared to each monotherapy. At the study end, mice in disease remission demonstrated reduced insulitis and detectable plasma C-peptide levels. When treatments were initiated in non-severely hyperglycemic NOD mice at diabetes onset, the combination treatment led to persistent disease remission in all mice. These results provide preclinical validation and rationale to investigate the combination of ACT-777991 with anti-CD3 for the treatment of patients with recent-onset diabetes." @default.
• W4384524084 created "2023-07-18" @default.
• W4384524084 creator A5007988649 @default.
• W4384524084 creator A5021683292 @default.
• W4384524084 creator A5022868338 @default.
• W4384524084 creator A5028668217 @default.
• W4384524084 creator A5036056372 @default.
• W4384524084 creator A5049875519 @default.
• W4384524084 creator A5057670277 @default.
• W4384524084 creator A5081955261 @default.
• W4384524084 creator A5085217351 @default.
• W4384524084 creator A5086793789 @default.
• W4384524084 creator A5092485540 @default.
• W4384524084 date "2023-07-17" @default.
• W4384524084 modified "2023-10-18" @default.
• W4384524084 title "Combination treatment of a novel CXCR3 antagonist ACT-777991 with an anti-CD3 antibody synergistically increases persistent remission in experimental models of type 1 diabetes" @default.
• W4384524084 cites W1484857603 @default.
• W4384524084 cites W1517524419 @default.
• W4384524084 cites W1779557997 @default.
• W4384524084 cites W1823467089 @default.
• W4384524084 cites W1896586019 @default.
• W4384524084 cites W1995201985 @default.
• W4384524084 cites W1997773579 @default.
• W4384524084 cites W2009253992 @default.
• W4384524084 cites W2032218738 @default.
• W4384524084 cites W2046749316 @default.
• W4384524084 cites W2057043713 @default.
• W4384524084 cites W2057328452 @default.
• W4384524084 cites W2066572646 @default.
• W4384524084 cites W2074463323 @default.
• W4384524084 cites W2082137006 @default.
• W4384524084 cites W2090613865 @default.
• W4384524084 cites W2094736478 @default.
• W4384524084 cites W2097687485 @default.
• W4384524084 cites W2098954537 @default.
• W4384524084 cites W2103302952 @default.
• W4384524084 cites W2146664729 @default.
• W4384524084 cites W2164707000 @default.
• W4384524084 cites W2169510681 @default.
• W4384524084 cites W2169866299 @default.
• W4384524084 cites W2544255112 @default.
• W4384524084 cites W2554850815 @default.
• W4384524084 cites W2746133516 @default.
• W4384524084 cites W2805560670 @default.
• W4384524084 cites W2807893746 @default.
• W4384524084 cites W2887373570 @default.
• W4384524084 cites W2904763939 @default.
• W4384524084 cites W2948104235 @default.
• W4384524084 cites W3111471920 @default.
• W4384524084 cites W3120451096 @default.
• W4384524084 cites W3133678581 @default.
• W4384524084 cites W3216791550 @default.
• W4384524084 cites W4313621194 @default.
• W4384524084 cites W4323294961 @default.
• W4384524084 cites W4323533159 @default.
• W4384524084 cites W4385302724 @default.
• W4384524084 doi "https://doi.org/10.1093/cei/uxad083" @default.
• W4384524084 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37458220" @default.
• W4384524084 hasPublicationYear "2023" @default.
• W4384524084 type Work @default.
• W4384524084 citedByCount "0" @default.
• W4384524084 crossrefType "journal-article" @default.
• W4384524084 hasAuthorship W4384524084A5007988649 @default.
• W4384524084 hasAuthorship W4384524084A5021683292 @default.
• W4384524084 hasAuthorship W4384524084A5022868338 @default.
• W4384524084 hasAuthorship W4384524084A5028668217 @default.
• W4384524084 hasAuthorship W4384524084A5036056372 @default.
• W4384524084 hasAuthorship W4384524084A5049875519 @default.
• W4384524084 hasAuthorship W4384524084A5057670277 @default.
• W4384524084 hasAuthorship W4384524084A5081955261 @default.
• W4384524084 hasAuthorship W4384524084A5085217351 @default.
• W4384524084 hasAuthorship W4384524084A5086793789 @default.
• W4384524084 hasAuthorship W4384524084A5092485540 @default.
• W4384524084 hasBestOaLocation W43845240841 @default.
• W4384524084 hasConcept C114684123 @default.
• W4384524084 hasConcept C126322002 @default.
• W4384524084 hasConcept C12823836 @default.
• W4384524084 hasConcept C13373296 @default.
• W4384524084 hasConcept C134018914 @default.
• W4384524084 hasConcept C147483822 @default.
• W4384524084 hasConcept C159654299 @default.
• W4384524084 hasConcept C165220095 @default.
• W4384524084 hasConcept C167672396 @default.
• W4384524084 hasConcept C203014093 @default.
• W4384524084 hasConcept C25532541 @default.
• W4384524084 hasConcept C2776090121 @default.
• W4384524084 hasConcept C2776999253 @default.
• W4384524084 hasConcept C2778013207 @default.
• W4384524084 hasConcept C2779511750 @default.
• W4384524084 hasConcept C2781232474 @default.
• W4384524084 hasConcept C555293320 @default.
• W4384524084 hasConcept C71924100 @default.
• W4384524084 hasConcept C8891405 @default.
• W4384524084 hasConcept C98274493 @default.
• W4384524084 hasConceptScore W4384524084C114684123 @default.
• W4384524084 hasConceptScore W4384524084C126322002 @default.
• W4384524084 hasConceptScore W4384524084C12823836 @default.
• W4384524084 hasConceptScore W4384524084C13373296 @default.
• W4384524084 hasConceptScore W4384524084C134018914 @default.
• W4384524084 hasConceptScore W4384524084C147483822 @default.

• next